Skip to main content
OGN
NYSE Life Sciences

苏恩药业据报以120亿美元收购奥格农,股价飙升41%

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
9
Price
$8.455
Mkt Cap
$2.201B
52W Low
$5.69
52W High
$13.245
Market data snapshot near publication time

summarizeSummary

苏恩药业有限公司据报已提交了一份120亿美元的全现金收购要约,以收购女性健康公司奥格农股份有限公司。这则最初由经济时报报道的消息导致奥格农的股价在开盘时飙升41%。拟议的收购代表了奥格农当前市值的显著溢价,表明该公司可能会经历一次变革性的事件。成功达成的交易将从根本上改变奥格农的战略方向和所有权。投资者现在将等待奥格农或苏恩药业有限公司的官方确认,以及任何潜在的竞价或监管审查。

在该公告发布时,OGN的交易价格为$8.46,交易所为NYSE,所属行业为Life Sciences,市值约为$22亿。 52周交易区间为$5.69至$13.25。 这则新闻被评估为积极市场情绪,重要性评分为9/10。 来源:Dow Jones Newswires。


show_chartPrice Chart

Share this article

Copied!

feed OGN - Latest Insights

OGN
Apr 27, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
10
OGN
Apr 26, 2026, 7:51 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
OGN
Apr 24, 2026, 4:35 PM EDT
Filing Type: DEFA14A
Importance Score:
7
OGN
Apr 24, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
OGN
Apr 24, 2026, 1:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
OGN
Apr 10, 2026, 10:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
OGN
Feb 20, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
7
OGN
Feb 12, 2026, 7:45 AM EST
Filing Type: 8-K
Importance Score:
8